View Item 

Show simple item record

Management of intracranial surgery for refractory epilepsy in severe factor VII deficiency: choosing the optimal dosing regimen
dc.contributor.authorRajpurkar, M.en_US
dc.contributor.authorCallaghan, M.en_US
dc.contributor.authorFrey, M. J.en_US
dc.contributor.authorSet, K.en_US
dc.contributor.authorChugani, H.en_US
dc.contributor.authorSood, S.en_US
dc.date.accessioned2014-05-23T15:59:14Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-05-23T15:59:14Z
dc.date.issued2014-05en_US
dc.identifier.citationRajpurkar, M.; Callaghan, M.; Frey, M. J.; Set, K.; Chugani, H.; Sood, S. (2014). "Management of intracranial surgery for refractory epilepsy in severe factor VII deficiency: choosing the optimal dosing regimen." Haemophilia 20(3): e234-e237.en_US
dc.identifier.issn1351-8216en_US
dc.identifier.issn1365-2516en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106864
dc.publisherWiley Periodicals, Inc.en_US
dc.titleManagement of intracranial surgery for refractory epilepsy in severe factor VII deficiency: choosing the optimal dosing regimenen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106864/1/hae12397.pdf
dc.identifier.doi10.1111/hae.12397en_US
dc.identifier.sourceHaemophiliaen_US
dc.identifier.citedreferenceChitlur M, Warrier I, Rajpurkar M et al. Thromboelastography in children with coagulation factor deficiencies. Br J Haematol 2008; 142: 250 – 6.en_US
dc.identifier.citedreferenceMariani G, Napolitano M, Dolce A et al. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation. Thromb Haemost 2013; 109: 238 – 47.en_US
dc.identifier.citedreferenceBrummel ZK, Rivard GE, Pouliot RL et al. Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2004; 2: 1735 – 44.en_US
dc.identifier.citedreferenceGirolami A, Berti de Marinis G, Vettore S, Girolami B. Congenital FVII deficiency and pulmonary embolism: a critical appraisal of all reported cases. Clin Appl Thromb Hemost 2013; 19: 55 – 9.en_US
dc.identifier.citedreferenceKim SH, Park YS, Kwon KH, Lee JH, Kim KC, Yoo MC. Surgery in patients with congenital factor VII deficiency: a single center experience. Korean J Hematol 2012; 47: 281 – 5.en_US
dc.identifier.citedreferenceSchulman S, Tjonnfjord GE, Wallensten R, Martinowitz U, Kenet G. Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII. Thromb Haemost 2005; 94: 1177 – 80.en_US
dc.identifier.citedreferenceMariani G, Dolce A, Batorova A et al. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STER. Br J Haematol 2011; 152: 340 – 6.en_US
dc.identifier.citedreferenceDi Minno MN, Dolce A, Mariani G. Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency. Thromb Haemost 2013; 109: 1051 – 9.en_US
dc.identifier.citedreferenceTran HT, Tjonnfjord GE, Paus A, Holme PA. rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency. Haemophilia 2011; 17: 764 – 70.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hae12397.pdf
Size:
153.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.